245 related articles for article (PubMed ID: 27158822)
1. Genome-Wide Analysis Identifies Germ-Line Risk Factors Associated with Canine Mammary Tumours.
Melin M; Rivera P; Arendt M; Elvers I; Murén E; Gustafson U; Starkey M; Borge KS; Lingaas F; Häggström J; Saellström S; Rönnberg H; Lindblad-Toh K
PLoS Genet; 2016 May; 12(5):e1006029. PubMed ID: 27158822
[TBL] [Abstract][Full Text] [Related]
2. The ESR1 gene is associated with risk for canine mammary tumours.
Borge KS; Melin M; Rivera P; Thoresen SI; Webster MT; von Euler H; Lindblad-Toh K; Lingaas F
BMC Vet Res; 2013 Apr; 9():69. PubMed ID: 23574728
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of PALB2 gene WD40 domain in canine mammary tumour patients.
Çıldır ÖŞ; Özmen Ö; Kul S; Rişvanlı A; Özalp G; Sabuncu A; Kul O
Vet Med Sci; 2024 May; 10(3):e1366. PubMed ID: 38527110
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis.
Hussain S; Saxena S; Shrivastava S; Mohanty AK; Kumar S; Singh RJ; Kumar A; Wani SA; Gandham RK; Kumar N; Sharma AK; Tiwari AK; Singh RK
PLoS One; 2018; 13(12):e0208656. PubMed ID: 30517191
[TBL] [Abstract][Full Text] [Related]
5. Malignant canine mammary tumours: Preliminary genomic insights using oligonucleotide array comparative genomic hybridisation analysis.
Santos M; Dias-Pereira P; Williams C; Lopes C; Breen M
Vet J; 2017 Apr; 222():68-71. PubMed ID: 28392153
[TBL] [Abstract][Full Text] [Related]
6. Differential stromal reprogramming in benign and malignant naturally occurring canine mammary tumours identifies disease-modulating stromal components.
Amini P; Nassiri S; Malbon A; Markkanen E
Sci Rep; 2020 Mar; 10(1):5506. PubMed ID: 32218455
[TBL] [Abstract][Full Text] [Related]
7. Characterization of HOX gene expression in canine mammary tumour cell lines from spontaneous tumours.
DeInnocentes P; Perry AL; Graff EC; Lutful Kabir FM; Curtis Bird R
Vet Comp Oncol; 2015 Sep; 13(3):322-36. PubMed ID: 24034269
[TBL] [Abstract][Full Text] [Related]
8. Common germline haplotypes and genotypes identified in BRCA2 exon 11 of dogs with mammary tumours and histopathological analyses.
Maués T; El-Jaick KB; Costa FB; Araujo GEF; Soares MVG; Moreira AS; Ferreira MLG; Ferreira AMR
Vet Comp Oncol; 2018 Sep; 16(3):379-384. PubMed ID: 29512278
[TBL] [Abstract][Full Text] [Related]
9. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype.
Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA
Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483
[TBL] [Abstract][Full Text] [Related]
10. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
Chen YC; Liao JW; Chang SC; Hsu WL
Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
[TBL] [Abstract][Full Text] [Related]
11. A Multi-Breed Genome-Wide Association Analysis for Canine Hypothyroidism Identifies a Shared Major Risk Locus on CFA12.
Bianchi M; Dahlgren S; Massey J; Dietschi E; Kierczak M; Lund-Ziener M; Sundberg K; Thoresen SI; Kämpe O; Andersson G; Ollier WE; Hedhammar Å; Leeb T; Lindblad-Toh K; Kennedy LJ; Lingaas F; Rosengren Pielberg G
PLoS One; 2015; 10(8):e0134720. PubMed ID: 26261983
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel genetic risk loci in Maltese dogs with necrotizing meningoencephalitis and evidence of a shared genetic risk across toy dog breeds.
Schrauwen I; Barber RM; Schatzberg SJ; Siniard AL; Corneveaux JJ; Porter BF; Vernau KM; Keesler RI; Matiasek K; Flegel T; Miller AD; Southard T; Mariani CL; Johnson GC; Huentelman MJ
PLoS One; 2014; 9(11):e112755. PubMed ID: 25393235
[TBL] [Abstract][Full Text] [Related]
13. Association between DLA-DRB1.2 allelic diversity and development of mammary gland tumors in dogs.
Vahedi SM; Nikbakht G; Jamshidi S; Lankarani L; Alimi N; Esmailnejad A
Acta Vet Scand; 2019 Nov; 61(1):55. PubMed ID: 31727096
[TBL] [Abstract][Full Text] [Related]
14. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
[TBL] [Abstract][Full Text] [Related]
15. Defect of the mitochondrial DNA hypervariable region as a risk factor for canine mammary tumour.
Surdyka M; Slaska B
Vet Comp Oncol; 2017 Sep; 15(3):820-828. PubMed ID: 27198058
[TBL] [Abstract][Full Text] [Related]
16. An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis.
Bertagnolli AC; Soares P; van Asch B; Amorim A; Cirnes L; Máximo V; Cassali GD
Vet J; 2009 Nov; 182(2):269-74. PubMed ID: 18752974
[TBL] [Abstract][Full Text] [Related]
17. Defect in ND2, COX2, ATP6 and COX3 mitochondrial genes as a risk factor for canine mammary tumour.
Surdyka M; Slaska B
Vet Comp Oncol; 2017 Sep; 15(3):1062-1072. PubMed ID: 27278673
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
19. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of canine mammary tumours on the Canary Archipelago in Spain.
Rodríguez J; Santana Á; Herráez P; Killick DR; de Los Monteros AE
BMC Vet Res; 2022 Jul; 18(1):268. PubMed ID: 35821034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
